AKI, acute kidney injury; AUROC, area under the receiver operator characteristic; OR, odds ratio; RIFLE, Risk Injury Failure Loss End-stage renal disease; RIFLE SCr , RIFLE criteria based on the serum creatinine criteria only; RIFLE SCr+OU , RIFLE criteria based on serum creatinine and urine output criteria; SAPS, Simplifi ed Acute Physiology Score; SCr, serum creatinine; UO, urine output.
In a recent issue of Critical Care, we read with interest the article by Wlodzimirow and colleagues [1] , who prospectively studied the Risk Injury Failure Loss Endstage renal disease (RIFLE) [2] classifi cation with serum creatinine (SCr) and urine output (UO) (RIFLE SCr+UO ) and without UO criteria (RIFLE SCr ) for acute kidney injury (AKI) in 260 critically ill patients. RIFLE SCr signifi cantly underestimated the presence of AKI on admission and during the fi rst week in the intensive care unit and signifi cantly delayed AKI diagnosis. Th ose are important fi ndings that corroborate the utility of simultaneously using both criteria as proposed by the Acute Dialysis Quality Initiative workgroup [2] . Th e authors also found that RIFLE SCr was associated with higher mortality than RIFLE SCr+UO . Th is observation should be interpreted with extreme caution, as this association has not been tested by multivariate analysis. Data regarding the impact on mortality of RIFLE defi ned by SCr and UO or by SCr are not conclusive. For example, in a systematic review, the relative risk for death among studies that used RIFLE SCr+UO was lower than in those using RIFLE SCr [3] . Previously, however, we did not fi nd any diff erence in terms of mortality for RIFLE SCr+UO 
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We agree with Lopes and Jorge that multivariate analysis should be attempted when testing whether RIFLE SCr is associated with higher mortality than RIFLE SCr+UO . Essentially the question is whether the group (hereafter G 1 ) of patients with AKI based on the RIFLE SCr criteria (regardless of UO) is at higher risk of death than the group (hereafter G 2 ) classifi ed as having AKI based on the UO criteria only. Additional analysis, not reported in [1] , shows that out of admission type, age, gender, weight, Acute Physiology and Chronic Health Evaluation (APACHE) score, Simplifi ed Acute Physiology Score (SAPS), cardiopulmonary resuscitation, and length of stay, only SAPS was a confounder. Before adjustment for SAPS, patients in G 1 had 1.64 times the odds of dying than those in G 2 . After adjustment for SAPS, the OR was reduced to 1.45 (P = 0.0004), still confi rming our fi ndings, which are in agreement with those of the other study [3] .
Th e seeming contradiction between our fi ndings and those of Lopes and colleagues [4] is easily explained by the signifi cant diff erences in case mix. In our study, 48.6% of the RIFLE SCr+UO AKI patients were classifi ed as having AKI on the basis of the UO criteria only [1] versus 5.6% in the study by Lopes and colleagues [4] . Diff erences in case mix may be attributable to the diff erent inclusion criteria, the Modifi cation of Diet in Renal Disease (MDRD)-based estimation of baseline SCr in all patients in the previous study [4] , which may overestimate AKI based on SCr [5] , and the outcome defi nition. All of these are important factors to consider when comparing studies.
